Mithra Pharmaceuticals S.A.

Report Publication Announcement • Mar 5, 2020

Mithra to Host Webcast for Announcement 2019 Financial Results on 9 March 2020

Liege, Belgium, 05 March 2020 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that it will host a live webcast on Monday 9 March 2020 at 15:00 CET/ 09:00 EST to announce its 2019 financial and operating results.

The live webcast can be accessed on the Mithra website or by clicking here. To participate in the questions and answers session, please call one of the numbers below, five to ten minutes prior to scheduled start of the call. A replay of the webcast will be available on the Mithra investor's website shortly after the close of the call.

Conference call dial-ins:

• Belgium, Brussels: +32 (0) 2 792 0434
• Netherlands, Amsterdam: +31 (0) 20 794 8426
• United States, New York: +1 212 999 6659
• Standard International Access: +44 (0) 20 3003 2666

Access code: Mithra

********

For more information, please contact:

Alexandra Deschner (IRO) : +32 490 58 35 23 - investorrelations@mithra.com Maud Vanderthommen (Press) : +32 473 58 61 04 – press@mithra.com

About Mithra

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra's goal is to develop products offering better efficacy, safety and convenience, meeting women's needs throughout their life span. Its three lead development candidates are built on Mithra's unique native estrogen platform, Estetrol (E4): Estelle®, a new era in oral contraception, PeriNesta®, the first complete oral treatment for perimenopause and Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 85 countries around the world, Mithra has an approximate headcount of 250 staff members and is headquartered in Liège, Belgium. www.mithra.com

Important information

The contents of this announcement include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes", "estimates," "anticipates", "expects", "intends", "may", "will", "plans", "continue", "ongoing", "potential", "predict", "project", "target", "seek" or "should", and include statements the Company

makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. The Company's actual results may differ materially from those predicted by the forwardlooking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

To receive our press releases by email, please subscribe to our mailing list on investors.mithra.com